Health / Genomic Revolution

This biotech-focused fund is based on companies that are involved in genomics. Areas of interest include companies that develop, produce or enable targeted therapeutics, bioinformatics, stem cells or molecular diagnostics. Most of the holdings in this actively managed fund are US healthcare companies.

ARKG ARK Genomic Revolution ETF

106.71% YTD
Low: High:

Due to technical variations, the pricing for this CFD may differ from the trading platform price.

payments methods payments methods